Hence, the inhibition of Ces1d/CES1 through genetic or pharmacologic means resulted in the death of colorectal cancer (CRC) cells under conditions of nutrient deprivation in laboratory settings and reduced CRC growth in animal models. This evidence concerns the gene CES1 and colorectal carcinoma.